Ethox Seminar: Subgroups and equity in cost-effectiveness analysis
Abstract
Cost-effectiveness analysis (CEA) aims to evaluate the additional amount of health that an intervention provides to patients and how much more it costs compared to alternatives. While many health systems have used CEA for decades to inform coverage or reimbursement policies, in the US, it is now a contested political issue. One group of critics contend that CEA may be used to identify patient subgroups who are cost-ineffective to treat, resulting in treatment denials and discrimination. Recently, new perspectives on CEA argue that subgroups should be included to identify opportunities to advance health equity. Given these conflicting claims, this paper considers when subgroup analysis is justifiable and how results should be implemented.

This will be a hybrid seminar in the Richard Doll Building Lecture Theatre or on Zoom (medsci.zoom.us/j/92573286349).
Date: 3 June 2025, 10:30
Venue: Richard Doll Building, Old Road Campus OX3 7LF
Venue Details: Lecture Theatre
Speaker: Dr Leah Rand (Brigham and Women's Hospital, Boston MA)
Organising department: Ethox Centre
Organiser: Aileen Mooney (University of Oxford)
Organiser contact email address: admin@ethox.ox.ac.uk
Part of: Ethox Centre Seminars
Booking required?: Not required
Audience: Public
Editors: Aileen Mooney, Shakira Morar